Portfolio company
DxLab
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops point-of-care molecular testing systems and rapid diagnostic tests for pathogens to serve healthcare providers and public health teams.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
StatDx
This company develops point-of-care molecular diagnostic systems for healthcare providers to identify infectious diseases and critical care conditions.
D-Nome
This company develops point-of-care molecular diagnostic kits and genomic sequencing tools for healthcare providers, laboratories, and agricultural clients to detect infectious diseases.
Pictura Bio
This company develops point-of-care diagnostic tools using machine learning and microscopy to identify pathogens in respiratory samples for clinicians and healthcare providers.
Nanopath
This company develops point-of-care molecular diagnostic tests and hardware for pelvic and gynecologic infections to provide rapid results for healthcare providers and their patients.
Delve Bio
This company provides metagenomic next-generation sequencing tests and diagnostic software to clinicians and laboratories for identifying pathogens in infectious diseases.
NOWDiagnostics
This company develops and manufactures rapid over-the-counter and point-of-care diagnostic tests for consumers and healthcare professionals.
HandyLab
HandyLab manufactures molecular diagnostic systems for clinical laboratories to automate the detection of infectious diseases.
Pattern Diagnostics
This company develops single-cell microbiology systems for rapid pathogen identification and antibiotic susceptibility testing, serving hospital and clinical microbiology laboratories.
